Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In collaboration with Cambodian authorities, MORU are running the Village Drama Against Malaria project for the third year. The project, which runs in 10 remote villages in March 2018, aims to create awareness about malaria prevention and early treatment.

2 children on stage during a theatre performance

In collaboration with Cambodian authorities and a local Cambodia theatre group, MORU are running the Village Drama Against Malaria project in Siem Pang district, Stung Treng province. This is the third year we are running this project. The project runs from 25th Feb to 29th March 2018 and will be in 10 villages, some of them very remote farming villages with close to the border with Laos along the Sikong river. Most of these villages are remote and populated by Lao and other ethnic minority peoples. 

The aim of the project is to create awareness about malaria prevention and early treatment; and infant vaccination using art and theater as engagement tools and leveraging traditional ethnic arts.

The theatre group goes from one village to another conducting art and theatre workshops with village children and young people. They also invite villagers to share their traditional tools, costumes. arts and dances. On the third evening, there is a public performance at the village square where there are games, singing competitions, malaria quizzes, and a comedy sketch about malaria – performed by village children.

The project is led by Nou Sanann (Public Engagement Officer) with support from Pich Kunthea, Tom Peto, Rupam Tripura, James Callery and Phaik Yeong Cheah, and is funded by a Wellcome Trust Provision for Public Engagement grant (supplement).

Similar stories

PLATCOV researchers find dramatic acceleration of SARS CoV2 viral clearance rates since Sept 2021

Running continuously since Sept 2021, the PLATCOV trial has randomised over 1700 patients presenting with COVID19 infections. Work by PLATCOV’s Dr Phrutsamon Wongnak published in the Lancet Infectious Diseases has shown that rates of oropharyngeal viral clearance have accelerated dramatically since the trial started: A SARS CoV2 viral clearance half-life in untreated patients of around 16 hours In Sept 2021 had reduced to around 9 hours by Oct 2023. The results highlight the importance of pharmacometric platform trials like PLATCOV, so that we are prepared for the next pandemic.